Samelisant

N/A

Report date: 2026/04/21 20:00:18
NME

Base Information

Drug NameSamelisant
Drug Alias NameSUVN-G3031
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H3 receptor antagonists
TargetsHistamine H3 receptor
Therapy Area/IndicationsCognition DisordersNarcolepsy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesSuven Life Sciences Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSuven Life Sciences Ltd
Inactive CompaniesN/A
Active IndicationsNarcolepsy
Inactive IndicationsCognition Disorders

Other Information

ATC CodeN/A
Related LinksN/A